- Citigroup Close to Reaching Deal With Government
- RBS Set for Record UK Loss of Up to $40 Billion
- Singapore Economy Shrinks by 16.4% in Fourth Quarter
- Are Any Bank Stocks Safe For Investors to Buy Yet?
- Geithner: Bankers to Blame for Loss of Confidence
- CNBC.com Exclusive: Interview With FDIC's Sheila Bair
- Asian Markets Turn Lower on Weak Yen, Poor Data
- Rich Americans Sue UBS to Keep Names Secret
- Warren Buffett Letter to Be Posted Saturday
- Lightning Round: IBM, Nucor, Con Ed and More
- Lightning Round OT: AstraZeneca, Teck Cominco and More
- How to Pick Gold Stocks
- A Bank Rally?
- Your First Move For Thursday February 26th
- Web Extra: Fast & Furious Trades For Thursday
- Pops & Drops: JPMorgan, General Motors...
- Warren Buffett Letter To Be Posted At 8A ET Saturday
- Can Pessimism Prolong Downturn?
Vertex Founder to Retire as President, CEO
Topics:CEOs and CFOs | Stock Market | Corporate News
Companies:Vertex Pharmaceuticals Incorporated | Companies
Text Size 
Biotechnology company Vertex Pharmaceuticals [VRTX
Loading...
()
] said on Thursday its president, chief executive and founder, Joshua Boger, 57, will retire in May and named board member Matthew Emmens, also 57, as his replacement.
Emmens, nonexecutive chairman of Shire, will also assume the posts of CEO and chairman in May, the company said.
Vertex Chairman Charles Sanders will remain as lead director on the company's board. Boger will remain an active member of the board.
Copyright 2009 Reuters. Click for restrictions.
Print
Email
MORE FROM CNBC
Data is a real-time snapshot *Data is delayed at least 15 minutes